Characteristics of the risk score based on IMRGs signature Patients in early clinical stages (I–II) generally exhibited lower risk scores compared to those in advanced stages (III-IV), although the p-value did not reach statistical significance (Fig. 4 A).
← all excerpts
Integrating iron metabolism-related gene signature to evaluate prognosis and immune infiltration in nasopharyngeal carcinoma.
1
—
—